Reuters logo
Eli Lilly says profit falls, to mull sale of animal health business
October 24, 2017 / 10:34 AM / a month ago

Eli Lilly says profit falls, to mull sale of animal health business

Oct 24 (Reuters) - Eli Lilly and Co, one of the world’s top insulin makers, on Tuesday reported a 28.5 percent drop in quarterly profit and said it was reviewing options, including a sale or an IPO, for its Elanco Animal Health business.

The company said its net income fell to $555.6 million, or 53 cents per share, in the third quarter ended Sep. 30, from $778 million, or 73 cents per share, a year earlier.

Revenue rose nearly 9 percent to $5.66 billion. (Reporting by Tamara Mathias in Bengaluru; Editing by Savio D‘Souza)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below